BRC News

The £26 million project is accelerating the search for effective treatments.

A study shows it is possible to cut the time for diagnostic MRI scans for dementia to one third of their standard length.

A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with specific genetic mutations, finds a major international trial.

UCLH has produced a short video to support members of Black communities who may be considering taking part in health research.

The study is BRC supported and took place at the NIHR UCLH Clinical Research Facility.

Three BRC-supported clinicians at UCL and UCLH contributed to the analysis.

The CCTU who won the award at the UCLH Celebrating Excellence Awards 2025.

A quicker, cheaper MRI scan has been shown to be as accurate at diagnosing prostate cancer as the current 30-40 minute scan.

The results suggest the tool could reduce unplanned ICU admissions after surgery tenfold.

The BRC-supported trial is now welcoming its first participants who will be recruited via memory clinics across the UK.

Sinus surgery is more effective than antibiotics at treating chronic rhinosinusitis, according to a major clinical trial.

Results are from a clinical trial led by a UCL professor and supported by the BRC.

Dr Gita Ramdharry, physiotherapist and Consultant Allied Health Professional at UCLH, will lead research in rare neurological diseases.

The registry could help bring about new treatments.

Response rates to immunotherapy treatment for prostate cancer patients improves markedly when specific molecular features of the tumour are selected for, a new clinical trial shows.